EVGN

#6381
EVOGENE LTD.
0.88
+4.76%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
0.88
0.88
Годовой диапазон
0.81
2.42
Дневное изменение
+4.76%
Месячное изменение
-20.00%
6-месячное изменение
-33.33%
Годовое изменение
-38.03%
Предыдущее закрытие
0.84
Open
0.88
Bid
Ask
Low
0.88
High
0.88
Объем
1
Open full chart

Financials

Overview Отчетность Statistics Dividends
Quarterly Annual
  • Market Capitalization N/A
  • Employee 75
  • Founded 1999
  • CEO Ofer Haviv
  • Website www.evogene.com
  • Headquarter Israel
  • FIGI UNKNOWN
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Evogene Ltd

Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture.

Новости